Financial Snapshot: Analyzing Akero Therapeutics Inc (AKRO)’s Key Ratio Metrics

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $51.47 for the day, down -0.46% from the previous closing price of $51.71. In other words, the price has decreased by -$0.46 from its previous closing price. On the day, 5.23 million shares were traded. AKRO stock price reached its highest trading level at $57.48 during the session, while it also had its lowest trading level at $49.38.

Ratios:

Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 27, 2025, Reiterated its Buy rating but revised its target price to $72 from $50 previously.

On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 27 ’25 when CATRIONA YALE bought 53,591 shares for $26.18 per share.

CATRIONA YALE bought 69,073 shares of AKRO for $1,808,331 on Jan 27 ’25. On Jan 27 ’25, another insider, PATRICK D LAMY, who serves as the Officer of the company, bought 6,000 shares for $26.18 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 3592564992 and an Enterprise Value of 2911674112.

Stock Price History:

The Beta on a monthly basis for AKRO is -0.14, which has changed by 1.3928738 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $15.32. The 50-Day Moving Average of the stock is 74.41%, while the 200-Day Moving Average is calculated to be 95.99%.

Shares Statistics:

AKRO traded an average of 962.62K shares per day over the past three months and 2476570 shares per day over the past ten days. A total of 69.61M shares are outstanding, with a floating share count of 58.32M. Insiders hold about 16.44% of the company’s shares, while institutions hold 97.86% stake in the company. Shares short for AKRO as of 1736899200 were 3350004 with a Short Ratio of 3.48, compared to 1734048000 on 3298482. Therefore, it implies a Short% of Shares Outstanding of 3350004 and a Short% of Float of 4.9399999999999995.

Most Popular